Dublin, April 05, 2023 (GLOBE NEWSWIRE) -- The "Specimen Validity Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Specimen Validity Testing estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$3.9 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030.
Products, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$2.6 Billion by the end of the analysis period.
Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 6.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $756.4 Million, While China is Forecast to Grow at 4.9% CAGR
The Specimen Validity Testing market in the U.S. is estimated at US$756.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$683.2 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
Select Competitors (Total 42 Featured) -
- Acm Global Laboratories
- Alfa Scientific Designs, Inc.
- Clinical Reference Laboratory, Inc.
- Express Diagnostics Int'l, Inc.
- Premier Brands of America, Inc.
- Quest Diagnostics, Inc.
- Sciteck, Inc.
- Thermo Fisher Scientific, Inc.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 173 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $2.6 Billion |
| Forecasted Market Value (USD) by 2030 | $3.9 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Specimen Validity Testing Market: Overview & Outlook
- Specimen Validity Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Increased Prevalence of Substance Abuse: Major Growth Driver
- Governmental Efforts to Alleviate Drug Abuse Builds Robust Business Case
- Increased Emphasis on Workplace Drug Testing Augurs Well
- Saliva Drug Testing: More Suitable for Workplace Testing
- Emphasis on Creating A Drug-Free Workplace
- Marijuana Testing Gathers Pace
- Relevance of Drug Testing for Medical Professionals Drives Demand
- Increased Opportunities in Alcohol Testing Vertical
- Growing Use Case in Rehabilitation Centers
- Regulations
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/f8nb5d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
